Clinical Trials Directory

Trials / Completed

CompletedNCT02633488

Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University of Virginia · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to look at how insulin (a hormone that helps the cells get energy from sugar) in our body affects blood vessels (elasticity in the bigger blood vessels and blood flow in the smaller blood vessels in the arm) and how Metformin (a drug that makes you more sensitive to insulin) affects insulin's action on the blood vessels.

Detailed description

In our protocol, we will study vascular function using pulse wave velocity (PWV) augmentation index (AI), flow mediated dilation (FMD) and contrast enhanced ultrasound (CEU) as well as insulin sensitivity (euglycemic clamp) in 50 adults with metabolic syndrome, age 18-60 years. They will each be studied 4 times,before and after two 12-wk interventions (randomly assigned) as follows: 1) Placebos and 2) Metformin . This is a cross-over design.

Conditions

Interventions

TypeNameDescription
DRUGPlacebosA 12 week single blind placebos
DRUGmetforminA 12 week single blind metformin

Timeline

Start date
2014-06-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-12-17
Last updated
2020-03-23
Results posted
2020-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02633488. Inclusion in this directory is not an endorsement.